The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The value of RCAS1 as a potential biomarker in non-small cell lung cancers.
Nikolaos Tsoukalas
No relevant relationships to disclose
Ioannis Kostakis
No relevant relationships to disclose
Spiros Siakavellas
No relevant relationships to disclose
Maria Tolia
No relevant relationships to disclose
Aristoula Papakostidi
No relevant relationships to disclose
Andreas Karameris
No relevant relationships to disclose
Alexandros Tzovaras
No relevant relationships to disclose
Ioannis Sfiniadakis
No relevant relationships to disclose
Evangelos Tsiambas
No relevant relationships to disclose
Alexandros Ardavanis
No relevant relationships to disclose
Evangelos Manolis
No relevant relationships to disclose
Christos Kittas
No relevant relationships to disclose
Stamatios Theocharis
No relevant relationships to disclose